These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36949118)

  • 21. Comparative genomics, evolutionary epidemiology, and RBD-hACE2 receptor binding pattern in B.1.1.7 (Alpha) and B.1.617.2 (Delta) related to their pandemic response in UK and India.
    Chakraborty C; Sharma AR; Bhattacharya M; Mallik B; Nandi SS; Lee SS
    Infect Genet Evol; 2022 Jul; 101():105282. PubMed ID: 35427787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions.
    Arantes I; Gomes Naveca F; Gräf T; ; Miyajima F; Faoro H; Luz Wallau G; Delatorre E; Reis Appolinario L; Cavalcante Pereira E; Venas TMM; Sampaio Rocha A; Serrano Lopes R; Mendonça Siqueira M; Bello G; Cristina Resende P
    Microbiol Spectr; 2022 Oct; 10(5):e0264121. PubMed ID: 36000897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spike protein mutational landscape in India during the complete lockdown phase: Could Muller's ratchet be a future game-changer for COVID-19?
    Banerjee R; Basak K; Ghosh A; Rajachandran V; Sureka K; Ganguly D; Chattopadhyay S
    Infect Genet Evol; 2021 Aug; 92():104874. PubMed ID: 33905891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
    Saito A; Irie T; Suzuki R; Maemura T; Nasser H; Uriu K; Kosugi Y; Shirakawa K; Sadamasu K; Kimura I; Ito J; Wu J; Iwatsuki-Horimoto K; Ito M; Yamayoshi S; Loeber S; Tsuda M; Wang L; Ozono S; Butlertanaka EP; Tanaka YL; Shimizu R; Shimizu K; Yoshimatsu K; Kawabata R; Sakaguchi T; Tokunaga K; Yoshida I; Asakura H; Nagashima M; Kazuma Y; Nomura R; Horisawa Y; Yoshimura K; Takaori-Kondo A; Imai M; ; Tanaka S; Nakagawa S; Ikeda T; Fukuhara T; Kawaoka Y; Sato K
    Nature; 2022 Feb; 602(7896):300-306. PubMed ID: 34823256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai.
    Shetty A; Chatterjee G; Rajpal S; Srivastava T; Gardi N; Mirgh S; Gokarn A; Punatar S; Shetty N; Joshi A; Nair S; Murthy V; Khattry N; Tembhare P; Dikshit R; Chaturvedi P; More A; Kamtalwar S; Chavan P; Bhat V; Patil A; Dhumal S; Bhat P; Subramanian P; Gujral S; Badwe R; Patkar N; Gupta S
    Int J Clin Pract; 2022; 2022():2449068. PubMed ID: 35685574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomics of postvaccination SARS-CoV-2 infections during the Delta dominated second wave of COVID-19 pandemic, from Mumbai Metropolitan Region (MMR), India.
    Nilgiriwala K; Kadam P; Patel G; Shaikh A; Mestry T; Vaswani S; Sakthivel S; Poojary A; Gandhi B; Rohra S; Udwadia Z; Oswal V; Shah D; Gomare M; Sriraman K; Mistry N
    J Med Virol; 2022 Sep; 94(9):4206-4215. PubMed ID: 35578378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
    Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-genome sequencing of SARS-CoV-2 reveals diverse mutations in circulating Alpha and Delta variants during the first, second, and third waves of COVID-19 in South Kivu, east of the Democratic Republic of the Congo.
    Ntagereka PB; Oyola SO; Baenyi SP; Rono GK; Birindwa AB; Shukuru DW; Baharanyi TC; Kashosi TM; Buhendwa JC; Bisimwa PB; Kusinza AB; Basengere RA; Mukwege D
    Int J Infect Dis; 2022 Sep; 122():136-143. PubMed ID: 35598737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Containment strategies for COVID-19 in India: lessons from the second wave.
    Asrani P; Tiwari K; Eapen MS; Hassan MDI; Sohal SS
    Expert Rev Anti Infect Ther; 2022 Jun; 20(6):829-835. PubMed ID: 35098855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics.
    Oh C; Sashittal P; Zhou A; Wang L; El-Kebir M; Nguyen TH
    Appl Environ Microbiol; 2022 Apr; 88(7):e0228921. PubMed ID: 35285246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?
    Pascarella S; Ciccozzi M; Zella D; Bianchi M; Benedetti F; Benvenuto D; Broccolo F; Cauda R; Caruso A; Angeletti S; Giovanetti M; Cassone A
    J Med Virol; 2021 Dec; 93(12):6551-6556. PubMed ID: 34260088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
    Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.
    Yi B; Poetsch AR; Stadtmüller M; Rost F; Winkler S; Dalpke AH
    Epidemiol Infect; 2021 Jul; 149():e177. PubMed ID: 34325753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
    Singh UB; Rophina M; Chaudhry R; Senthivel V; Bala K; Bhoyar RC; Jolly B; Jamshed N; Imran M; Gupta R; Aggarwal P; Divakar MK; Sinha S; Arvinden VR; Bajaj A; Shamnath A; Jain A; ; Scaria V; Sivasubbu S; Guleria R
    J Med Virol; 2022 Apr; 94(4):1696-1700. PubMed ID: 34786733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 B.1.1.7 Decline Is Not Driven by the Introduction of a More Successful Variant.
    Rodríguez-Grande C; Buenestado-Serrano S; Alcalá L; Sola-Campoy PJ; Molero-Salinas A; Otero-Sobrino Á; Rodríguez-Grande J; de la Cueva García VM; Adán-Jiménez J; Rico-Luna C; Losada C; Catalán P; Muñoz P; Pérez-Lago L; García de Viedma D;
    Microbiol Spectr; 2021 Dec; 9(3):e0112821. PubMed ID: 34787494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.